These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2309938)

  • 1. Osmotic regulation of vasopressin and oxytocin release is rate sensitive in hypothalamoneurohypophysial explants.
    Yagil C; Sladek CD
    Am J Physiol; 1990 Feb; 258(2 Pt 2):R492-500. PubMed ID: 2309938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of extended exposure to hypertonicity on vasopressin messenger ribonucleic acid content in hypothalamo-neurohypophyseal explants.
    Yagil C; Sladek CD
    Endocrinology; 1990 Sep; 127(3):1428-35. PubMed ID: 2387259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osmotic control of vasopressin release by rat hypothalamo-neurohypophyseal explants in organ culture.
    Sladek CD; Knigge KM
    Endocrinology; 1977 Dec; 101(6):1834-8. PubMed ID: 590195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antisense oligodeoxynucleotides on peptide release from hypothalamoneurohypophysial explants.
    Ludwig M; Morris M; Sladek CD
    Am J Physiol; 1997 May; 272(5 Pt 2):R1441-6. PubMed ID: 9176335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the central vasopressin and oxytocin axis after lesion of a brain osmotic sensory region.
    Oliveira GR; Franci CR; Rodovalho GV; Franci JA; Morris M; Rocha MJ
    Brain Res Bull; 2004 Jul; 63(6):515-20. PubMed ID: 15249117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of metabotropic glutamate receptors in vasopressin and oxytocin release.
    Morsette DJ; Sidorowicz H; Sladek CD
    Am J Physiol Regul Integr Comp Physiol; 2001 Aug; 281(2):R452-8. PubMed ID: 11448847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A compartmentalized, organ-cultured hypothalamo-neurohypophysial system for the study of vasopressin release.
    Gregg CM; Sladek CD
    Neuroendocrinology; 1984 May; 38(5):397-402. PubMed ID: 6728121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of noradrenergic control of vasopressin release by the organ-cultured rat hypothalamo-neurohypophyseal system.
    Armstrong WE; Sladek CD; Sladek JR
    Endocrinology; 1982 Jul; 111(1):273-9. PubMed ID: 7084115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osmoregulation of the magnocellular system during pregnancy and lactation.
    Koehler EM; McLemore GL; Tang W; Summy-Long JY
    Am J Physiol; 1993 Mar; 264(3 Pt 2):R555-60. PubMed ID: 8457007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does conversion of ATP to adenosine terminate ATP-stimulated vasopressin release from hypothalamo-neurohypophyseal explants?
    Song Z; Sladek CD
    Brain Res; 2005 Jun; 1047(1):105-11. PubMed ID: 15893296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of negative feedback by oxytocin on release from magnocellular neurones in conscious rats.
    Cheng SW; North WG
    Can J Physiol Pharmacol; 1992 Jan; 70(1):100-5. PubMed ID: 1581842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anteroventral third ventricle lesions on vasopressin release by organ-cultured hypothalamo-neurohypophyseal explants.
    Sladek CD; Johnson AK
    Neuroendocrinology; 1983 Jul; 37(1):78-84. PubMed ID: 6888661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatile secretion pattern of vasopressin under basal conditions, after water deprivation, and during osmotic stimulation in dogs.
    van Vonderen IK; Wolfswinkel J; Oosterlaken-Dijksterhuis MA; Rijnberk A; Kooistra HS
    Domest Anim Endocrinol; 2004 Jul; 27(1):1-12. PubMed ID: 15158530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of naloxone on the release of neurohypophysial hormones in normotensive and spontaneously hypertensive rats.
    Rosella-Dampman LM; Emmert SE; Keil LC; Summy-Long JY
    Brain Res; 1985 Jan; 325(1-2):205-14. PubMed ID: 3978414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid changes in poly (A) tail length of vasopressin and oxytocin mRNAs form a common early component of neurohypophyseal peptide gene activation following physiological stimulation.
    Carter DA; Murphy D
    Neuroendocrinology; 1991 Jan; 53(1):1-6. PubMed ID: 1675437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of interleukin-1beta in the magnocellular system to salt-loading.
    Summy-Long JY; Hu S; Pruss A; Chen X; Phillips TM
    J Neuroendocrinol; 2006 Dec; 18(12):926-37. PubMed ID: 17076768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of opioid peptides on release from vasopressin and oxytocin neurones of the hypothalamoneurohypophyseal system: effects of naloxone in the conscious rat.
    Cheng SW; O'Connor EF; North WG
    Can J Physiol Pharmacol; 1990 May; 68(5):568-74. PubMed ID: 2340446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of the magnocellular system in rats to hypovolemia and cholecystokinin during pregnancy and lactation.
    Koehler EM; McLemore GL; Martel JK; Summy-Long JY
    Am J Physiol; 1994 Apr; 266(4 Pt 2):R1327-37. PubMed ID: 8184979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the cAMP/PKA signalling pathway in the inhibitory influence of melatonin on oxytocin and vasopressin secretion from the rat hypothalamo-neurohypophysial system.
    Juszczak M; Krzyminska A; Bojanowska E; Roszczyk M
    Endokrynol Pol; 2018; 69(5):560-566. PubMed ID: 30074234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.